Arrowhead Pharmaceuticals, Inc. (ARWR) vs Ionis Pharmaceuticals, Inc. (IONS)
- Arrowhead Pharmaceuticals, Inc. ARWR 55.90 −4.44%
- Ionis Pharmaceuticals, Inc. IONS 42.94 −2.67%
Arrowhead Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. is the larger, with a market value of $8.3B against $7.3B — 1.1× the size. Arrowhead Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 16.1% against −7.41%. Arrowhead Pharmaceuticals, Inc. has the higher net margin (−47.8% vs −64.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 13 and Ionis Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | ARWR | IONS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 98.17% | 65.16% |
| Operating margin | (33.82%) | (68.00%) | 0.00% |
| Net margin | (47.79%) | (64.66%) | 0.00% |
| Free cash flow margin | (11.22%) | (64.93%) | 0.00% |
| Return on equity | (64.91%) | (105.50%) | (56.36%) |
| Return on assets | (18.32%) | (18.90%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack